Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours

Technology appraisal guidance
Reference number: TA86
Published: 27 October 2004
Last updated: 01 November 2010

TA86 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders

TA86 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders

TA86 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders
27 August 2013
(101.59 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 23 August 2013